Ciclofilin pharmaceuticals inc
WebJul 28, 2015 · SAN DIEGO, July 28, 2015 (GLOBE NEWSWIRE) -- Ciclofilin Pharmaceuticals Inc. ("Ciclofilin" or the "Company"), a hepatitis B virus ("HBV") drug developer, announced today its lead antiviral drug candidate demonstrated significantly reduced liver HBV DNA in a transgenic mouse model. The study was conducted by the … WebMay 31, 2016 · CPI-431-32 is a highly potent derivative of cyclosporine, yet is engineered to be non-immunosuppressive. It selectively targets and inhibits host cellular enzymes …
Ciclofilin pharmaceuticals inc
Did you know?
WebMay 31, 2016 · Advanced search Log in WebFounder of Aurinia Pharmaceuticals, Inc. and Ciclofilin Pharmaceuticals, Inc., Robert T. Foster is a businessperson who has been the head of 5 different companies and currently holds the position of President, Chief Executive Officer & Director at Hepion Pharmaceuticals, Inc.
WebDec 2, 2015 · Investor Contact: Ciclofilin Pharmaceuticals, Inc. Dr. Robert T. Foster, CEO +1 (780) 909-5041 Email: [email protected] Mr. Michael Kamdar, President +1 … WebDec 31, 2024 · On June 13, 2016, we completed our merger with Ciclofilin Pharmaceuticals, Inc. (“CPI”) acquiring all its outstanding equity interests. We acquired Ciclofilin’s lead asset, CPI-431-32, which we renamed rencofilstat, strengthens our liver disease portfolio and is currently in preclinical development for the treatment of liver fibrosis.
WebJun 13, 2016 · Jun 13, 2016, 06:00 ET. EDISON, N.J., June 13, 2016 /PRNewswire/ -- ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV ), a biopharmaceutical company … WebAmendment No. 1 to NICAMS Purchase and Sale Agreement by and between Aurinia Pharmaceuticals Inc., Ciclofilin Pharmaceuticals Inc., an Alberta Corporation and Ciclofilin Pharmaceuticals, Inc., a Delaware corporation dated as of May 26, 2016 from ContraVir Pharmaceuticals, Inc. filed with the Securities and Exchange Commission.
WebCiclofilin Pharmaceuticals is a biopharmaceutical company specializing in development of. cyclophilin inhibitors, an emerging class of drugs for infectious, inflammatory, and …
WebJun 24, 2015 · SAN DIEGO, June 24, 2015 (GLOBE NEWSWIRE) -- Ciclofilin Pharmaceuticals Inc. ("Ciclofilin" or the "Company"), a hepatitis B virus ("HBV") drug … cit in normas apaWebMar 31, 2016 · View Full Report Card. Fawn Creek Township is located in Kansas with a population of 1,618. Fawn Creek Township is in Montgomery County. Living in Fawn … dibble ok public schoolsWebNational Center for Biotechnology Information dibble public schools employmentWebApr 10, 2024 · The projected discounted cash flow models used to estimate the fair values of our IPR&D assets, acquired in connection with the Ciclofilin acquisition, reflect significant assumptions regarding the estimates a market participant would make in order to evaluate a drug development asset, including: (i) probability of successfully completing ... dibble photographyWebRobert Foster, B.Sc. (Pharm), Pharm.D., Ph.D. Dr. Foster first began working on cyclophilin drug development in 1988, and brings more than 30 years of pharmaceutical and biotech experience to Hepion. Prior to … dibble public schools job openingsWebOct 27, 2014 · SAN DIEGO, Oct. 27, 2014 (GLOBE NEWSWIRE) -- Ciclofilin Pharmaceuticals Inc. ("Ciclofilin" or the "Company"), a developer of broad spectrum antiviral medications, announced today the appointment of Stephen F. Keane as Senior Vice President of Corporate Development. In this role, Mr. Keane will be responsible for … citi not syncing with mintWebPrior to Hepion, he was CEO and Founder of Ciclofilin Pharmaceuticals Inc., which merged with Hepion in 2016. Before that, he founded Isotechnika Pharma Inc. (TSX:ISA) in 1993, and was its Chairman and CEO for approximately 21 years. During his tenure at Isotechnika, Dr. Foster discovered voclosporin, an immunosuppressive drug to treat ... dibble public school